Antidepressant Therapy and Risk Diabetes in the Diabetes Prevention Program (DPP) Study

被引：0
|
作者：
Nowotny, B. [1 ]
机构：
[1] Univ Dusseldorf, Leibniz Zentrum Diabet Forsch, Deutsch Diabet Zentrum, Inst Klin Diabetol, D-40225 Dusseldorf, Germany
来源：
DIABETOLOGE | 2011年 / 7卷 / 01期
关键词：
D O I：
10.1007/s11428-010-0674-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] Antidepressant Medicine Use and Risk of Developing Diabetes During the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
    Rubin, Richard R.
    Ma, Yong
    Peyrot, Mark
    Marrero, David G.
    Price, David W.
    Barrett-Connor, Elizabeth
    Knowler, William C.
    [J]. DIABETES CARE, 2010, 33 (12) : 2549 - 2551
  • [2] Antidepressive Therapie und Diabetesrisiko in der „Diabetes Prevention Program- (DPP-) Study“Antidepressant medicine use and risk of developing diabetes during the Diabetes Prevention Program Outcomes Study
    B. Nowotny
    [J]. Der Diabetologe, 2011, 7 (1): : 33 - 33
  • [3] Menstrual Dysfunction, Hyperandrogenism, and Diabetes Risk in the Diabetes Prevention Program (DPP)
    Ehrmann, David A.
    Younes, Naji
    Kim, Catherine
    Kitabchi, Abbas E.
    Barrett-Connor, Elizabeth L.
    Mather, Kieren J.
    Carrion-Petersen, Marylou
    Edelstein, Sharon L.
    Aroda, Vanita R.
    Goldberg, Ronald B.
    [J]. DIABETES, 2016, 65 : A379 - A379
  • [4] Antidepressant Medication Use and Risk of Developing Diabetes during the Diabetes Prevention Program andthe Diabetes Prevention Program Outcomes Study
    Rubin, Richard R.
    Marrero, David G.
    Ma, Yong
    Knowler, William C.
    Price, David
    Barrett-Connor, Elizabeth
    Peyrot, Mark
    [J]. DIABETES, 2010, 59 : A128 - A129
  • [5] The Diabetes Prevention Program (DPP).
    不详
    [J]. DIABETES, 1997, 46 : 533 - 533
  • [6] Update on Diabetes Prevention Program (DPP)
    Mudaliar, S
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 779 - 779
  • [7] Autoimmunity and prevention of type 2 diabetes: the Diabetes Prevention Program (DPP)
    Dabelea, D.
    Ma, Y.
    Knowler, W. C.
    Marcovina, S.
    Saudek, C.
    Arakaki, R.
    White, N. H.
    Kahn, S.
    Haffner, S. M.
    Orchard, T.
    Goldberg, R.
    Hamman, R. F.
    [J]. DIABETOLOGIA, 2006, 49 : 192 - 192
  • [8] Physical Activity and Diabetes Development: The Diabetes Prevention Program (DPP) Outcomes Study
    Kriska, Andrea M.
    Rockette-Wagner, Bonny
    Edelstein, Sharon L.
    Venditti, Elizabeth M.
    Bray, George A.
    Delahanty, Linda M.
    Horton, Edward S.
    Hoskin, Mary A.
    Knowler, William C.
    [J]. DIABETES, 2016, 65 : A99 - A99
  • [9] Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program (DPP)
    [J]. DIABETES, 2003, 52 : A58 - A59
  • [10] Effects of the intensive lifestyle intervention (ILS) on risk of diabetes in the diabetes prevention program (DPP).
    Hamman, R
    [J]. DIABETOLOGIA, 2003, 46 : A38 - A38
12345